ALCAM and systemic lupus erythematosus: Among urinary biomarkers, the activated leucocyte cell adhesion molecule (ALCAM) could distinguish between renal and non-renal SLE and high baseline urinary ALCAM levels seemed to increase the risk for deterioration of renal function (20).